Active Funding:

“Smoke Induced Airway Injury in COPD”

• Grant Agency: NIH – R01 HL086936 (PI: Jeanine D’Armiento, M.D., Ph.D.)
• Yearly Direct Costs: $371,862 (February 19, 2007 – June 30, 2017)

“Targeting Matrix Metalloproteinases to Limit Immunopathology in Airborne Infection”

• Grant Agency: NIH — R33 AI102239 (PI: Paul Elkington, M.D., Ph.D., Co-PI: Jeanine D’Armiento, M.D., Ph.D.I)
• Yearly Direct Costs: $125,000 (July 1, 2014 – June 30th, 2017)

“In Vivo Imaging of Destructive Processes in COPD”

• Grant Agency: NIH – R01 HL131960 (PI: Jeanine D’Armiento, M.D., Ph.D.)
• Yearly Direct Costs: $439,234 (September 19, 2016 – June 30, 2019)

“Implications of MMP-13 Mediated Cleavage of Alpha-1 Antitrypsin”

• Grant Agency: Alpha-1 Foundation (PI: Jeanine D’Armiento, M.D., Ph.D.)
• Yearly Direct Costs: $100,000 (July 1, 2015 – June 30, 2017)

“LAM Pilot Study with Imatinib Mesylate (LAMP-1)”

• Grant Agency: Department of Defense W81XWH-14-1-0132
• Yearly Direct Costs: $12,500 (September 30, 2015 – September 29, 2017)

Recently Completed Grants:

“Inducible Macrophage Specific Gene Expression in Diseases”

• Grant Agency: NIH – ARRA-Challenge Grant RC HL100384 (PI: Jeanine D’Armiento, M.D., Ph.D.)
• Annual Amount: $305,000 (October 1, 2009 – September 30, 2011)

“Novel Mechanisms of MMP Induction in Vascular Smooth Muscle Cells”

• Grant Agency: American Heart Association – Established Investigator Award (PI: Jeanine D’Armiento, M.D., Ph.D.)
• Annual Amount: $100,000 (January 1, 2008 – December 31, 2012)

“Imaging RAGE Pro-Inflammatory Signaling and Cellular Apoptosis in Emphysema”

• Grant Agency: NIH – R01 HL116346 (PI: Jeanine D’Armiento, M.D., Ph.D.)
• Yearly Direct Costs: $245,000 (September 25, 2012 – June 30, 2015)